@article{ref1,
title="The effects of dextromethorphan on driving performance and the standardized field sobriety test",
journal="Journal of forensic sciences",
year="2015",
author="Perry, Paul J. and Fredriksen, Kristian and Chew, Stephanie and Ip, Eric J. and Lopes, Ingrid and Doroudgar, Shadi and Thomas, Kelan",
volume="60",
number="5",
pages="1258-1262",
abstract="Dextromethorphan (DXM) is abused most commonly among adolescents as a recreational drug to generate a dissociative experience. The objective of the study was to assess driving with and without DXM ingestion. The effects of one-time maximum daily doses of DXM 120 mg versus a guaifenesin 400 mg dose were compared among 40 healthy subjects using a crossover design. Subjects' ability to drive was assessed by their performance in a driving simulator (STISIM(®) Drive driving simulator software) and by conducting a standardized field sobriety test (SFST) administered 1-h postdrug administration. The one-time dose of DXM 120 mg did not demonstrate driving impairment on the STISIM(®) Drive driving simulator or increase SFST failures compared to guaifenesin 400 mg. Doses greater than the currently recommended maximum daily dose of 120 mg are necessary to perturb driving behavior.<p /> <p>Language: en</p>",
language="en",
issn="0022-1198",
doi="10.1111/1556-4029.12833",
url="http://dx.doi.org/10.1111/1556-4029.12833"
}